News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Kirin Brewery Co., Ltd. (KNBWY) , Sankyo Company, Ltd. (SKXOF.PK) To Terminate Joint Marketing Of Renal Anemia Drug ESPO And Leukopenia Drug GRAN By Next March


10/19/2005 5:11:50 PM

Leading Japanese beverage manufacturer Kirin Brewery (TSE:2503) announced that it has mutually agreed with Sankyo (TSE:4501) to terminate their agreement on joint sales of ESPO, a renal anemia drug, and GRAN, a leukopenia, by the end of March 2005. Consequently, Kirin will sell ESPO and GRAN as a sole distributor from April 2005.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES